Global Metabolomics Market - Size, Share, Trends, and Forecast 2026-2032 | AI, Multi-Omics, and Precision Medicine Drive 11.76% CAGR Toward USD 7.39 Billion
Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "Metabolomics Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.
The global metabolomics market research report examines a sector projected to grow from USD 3.78 billion in 2026 to USD 7.39 billion by 2032, representing a CAGR of 11.76%. It provides strategic insights into technologies, applications, adoption drivers, regional activity, artificial intelligence, and competitive priorities shaping metabolomics across healthcare, pharmaceuticals, nutrition, agriculture, toxicology, and environmental science.
Market Overview and Growth Drivers
Metabolomics measures small-molecule metabolites to reveal real-time biochemical activity influenced by genetics, microbiome composition, diet, medication, lifestyle, and environmental exposure. Its ability to characterize phenotype, disease progression, treatment response, and cellular metabolism is strengthening its role in systems biology and precision medicine.
Key demand drivers include:
The analysis helps decision-makers identify high-growth applications and align investment priorities with emerging clinical, scientific, and commercial opportunities.
Technology and Market Transformation
High-resolution mass spectrometry, nuclear magnetic resonance spectroscopy, liquid and gas chromatography, capillary electrophoresis, stable isotope tracing, and advanced bioinformatics are expanding analytical coverage. Targeted metabolomics supports precise pathway quantification, while untargeted approaches enable broad biomarker discovery.
Major shifts include:
These insights support technology selection, partnership evaluation, and differentiated market-entry strategies.
Artificial Intelligence in Metabolomics
Artificial intelligence is improving peak detection, feature alignment, spectral deconvolution, noise reduction, metabolite annotation, pathway interpretation, and predictive modeling. Machine learning can identify metabolic signatures associated with disease, therapeutic response, nutritional status, toxic exposure, and microbial activity.
Successful adoption depends on curated libraries, high-quality metadata, independent validation, explainability, bias assessment, and model monitoring. Combining automated analysis with biochemical and clinical expertise offers the strongest pathway from raw spectra to actionable findings.
Regional and Economic Group Insights
ASEAN, GCC, EU, BRICS, G7, and NATO markets display distinct research priorities and infrastructure maturity. Country-level coverage highlights leading activity in the United States, Canada, Mexico, Brazil, the United Kingdom, Germany, France, Russia, Italy, Spain, China, India, Japan, Australia, and South Korea. Regional comparisons enable organizations to assess expansion opportunities while mitigating infrastructure, regulatory, and workforce risks.
Strategic Priorities for Market Participants
Key Takeaways from This Report
Key Attributes:
Key Topics Covered:
1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter's Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Metabolomics Market, by Component
7.1. Introduction
7.2. Bioinformatics Tools & Services
7.2.1. Bioinformatics Services
7.2.2. Bioinformatics Tools & Databases
7.3. Metabolomic Instruments
7.3.1. Detection Tools
7.3.1.1. Mass Spectrometry
7.3.1.2. Nuclear Magnetic Resonance Spectroscopy
7.3.1.3. Surface-based Mass Analysis
7.3.2. Separation Tools
7.3.2.1. Capillary Electrophoresis
7.3.2.2. Gas Chromatography
7.3.2.3. High-Performance Liquid Chromatography
7.3.2.4. Ultra Performance Liquid Chromatography
8. Metabolomics Market, by Analytical Approach
8.1. Introduction
8.2. Untargeted Metabolomics
8.3. Semi-Targeted Metabolomics
8.4. Targeted Metabolomics
8.5. Stable-Isotope Tracing And Fluxomics
8.6. Spatial Metabolomics
9. Metabolomics Market, by Sample Type
9.1. Introduction
9.2. Human Biofluids
9.2.1. Blood, Plasma, And Serum
9.2.2. Urine
9.2.3. Cerebrospinal Fluid
9.2.4. Saliva
9.2.5. Breath Condensate And Exhaled Breath
9.3. Animal And Preclinical Samples
9.4. Plant And Agricultural Samples
9.5. Food And Beverage Samples
9.6. Environmental Samples
10. Metabolomics Market, by Indication
10.1. Introduction
10.2. Cardiovascular Disorders
10.3. Metabolic Disorders
10.4. Neurological Disorders
10.5. Oncological Disorders
11. Metabolomics Market, by Application
11.1. Introduction
11.2. Biomarker Discovery
11.2.1. Cancer Biomarkers
11.2.2. Neurological Biomarkers
11.3. Drug Discovery
11.3.1. Metabolic Pathways
11.3.2. Target Identification
11.4. Environmental Science
11.4.1. Pesticide Residue Analysis
11.4.2. Water Quality Analysis
11.5. Nutrigenomics
11.5.1. Cardiovascular Health
11.5.2. Obesity Research
11.6. Personalized Medicine
11.6.1. Genomic Studies
11.6.2. Therapeutic Monitoring
11.7. Toxicology Testing
12. Metabolomics Market, by End-User
12.1. Introduction
12.2. Academic Research Institutes
12.3. Contract Research Organizations
12.4. Pharmaceutical & Biotechnology Companies
13. Metabolomics Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Metabolomics Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Metabolomics Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Advanced Chemistry Development, Inc.
17.2. Advion, Inc.
17.3. Agilent Technologies, Inc.
17.4. Bruker Corporation
17.5. Cayman Chemical Company
17.6. Cerno Bioscience LLC
17.7. Chenomx Inc.
17.8. Clinical Microbiomics A/S
17.9. GERSTEL GmbH & Co. KG
17.10. Hitachi High-Tech Corporation
17.11. Human Metabolome Technologies, Inc.
17.12. JEOL Ltd.
17.13. LECO Corporation
17.14. Lipotype GmbH
17.15. Merck KGaA
17.16. Mestrelab Research S.L.
17.17. Metabolon, Inc.
17.18. metaSysX GmbH
17.19. Nightingale Health Plc
17.20. numares AG
17.21. Owlstone Medical Limited
17.22. Oxford Instruments plc
17.23. QIAGEN N.V.
17.24. Restek Corporation
17.25. Revvity, Inc.
17.26. Sapient Bioanalytics, LLC
17.27. SCION Instruments NL B.V.
17.28. Shimadzu Corporation
17.29. Thermo Fisher Scientific Inc.
17.30. Waters Corporation
18. Key Experts
List of Figures [23]
List of Tables [366]
For more information about this report visit https://www.researchandmarkets.com/r/k98mxm
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.